Similar articles

• Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.

  Yustin D, Kryshtalskyj B, Galea A. Yustin D, et al. J Orofac Pain. 1995 Fall;9(4):375-9. J Orofac Pain. 1995. PMID: 8995909
• Acute local reactions after intraarticular hylan for osteoarthritis of the knee.

  Adams ME. Adams ME. J Rheumatol. 1996 May;23(5):944-5; author reply 946. J Rheumatol. 1996. PMID: 8724316 No abstract available.
• Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis.

  Homma A, Sato H, Tamura T, Okamachi A, Emura T, Ishizawa T, Kato T, Matsuura T, Sato S, Higuchi Y, Watanabe T, Kitamura H, Asanuma K, Yamazaki T, Ikemi M, Kitagawa H, Morikawa T, Ikeya H, Maeda K, Takahashi K, Nohmi K, Izutani N, Kanda M, Suzuki R. Homma A, et al. Bioorg Med Chem. 2010 Feb;18(3):1062-75. doi: 10.1016/j.bmc.2009.12.053. Epub 2009 Dec 28. Bioorg Med Chem. 2010. PMID: 20060728
• Current thinking on viscosupplementation in osteoarthritis.

  Jay GD. Jay GD. Med Health R I. 2004 Jul;87(7):213-5. Med Health R I. 2004. PMID: 15354797 Review. No abstract available.
• Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?

  Brandt KD, Smith GN Jr, Simon LS. Brandt KD, et al. Arthritis Rheum. 2000 Jun;43(6):1192-203. doi: 10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L. Arthritis Rheum. 2000. PMID: 10857778 Review. No abstract available.